Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Peer Support Program for Improving Quality of Life Among Head and Neck Patients, Connecting Through Cancer Trial

13. juli 2026 opdateret af: Ryan Li, MD, OHSU Knight Cancer Institute

Connecting Through Cancer: Feasibility of a Peer Support Program for Head and Neck Patients

This clinical trial tests whether a peer support program is feasible for head and neck cancer patients. Social support at the time of diagnosis has been shown to improve head and neck cancer quality of life before and after treatment. However, not all patients have a strong social support system. Recent research has shown that peer support programs have the potential to address unmet social support needs among cancer patients. These programs involve cancer survivors (peer mentors) providing emotional and informational support to cancer patients (mentees) earlier in their disease course. Peer support programs may also reduce caregiver burden by providing an additional source of support for the patient. A one-on-one peer support program may be feasible for patients with head and neck cancer and their caregivers.

Studieoversigt

Status

Ikke rekrutterer endnu

Betingelser

Intervention / Behandling

Detaljeret beskrivelse

Primary objective:

I. Examine the feasibility of a peer support program for head and neck cancer patients.

Secondary objective:

I. Collect qualitative and quantitative data on the utilization of the mentorship program.

Exploratory objective:

I. Descriptive analysis of mentee psychosocial wellbeing over time. II. Descriptive analysis of caregiver burden over time.

Outline:

Patients ("mentees") participate in the peer support program by being matched with and meeting with a peer mentor, either virtually or in-person, during the study.

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

56

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Alexandria Lichtl, MD
  • Telefonnummer: 5037061729
  • E-mail: lichtl@ohsu.edu

Studiesteder

  • Forenede Stater
    • Oregon
      • Portland, Oregon, Forenede Stater, 97239
        • OHSU Knight Cancer Institute
        • Kontakt:
          • Ryan J. Li, MD
          • Telefonnummer: 302-893-4959
          • E-mail: lry@ohsu.edu
        • Ledende efterforsker:
          • Ryan J. Li, MD

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • MENTEE GROUP: Ability to understand and the willingness to sign a written informed consent document
  • MENTEE GROUP: Willingness to have mentor-mentee interactions with the mentor selected by Imerman Angels (documented as part of informed consent)
  • MENTEE GROUP: Age 18 or older at the time of consent (upper age limit 89)
  • MENTEE GROUP: Diagnosed with head & neck cancer (all stages) and planning to receive, currently receiving or recently completed (within 12 months) active treatment OR in follow-up and reporting unmet social/support needs
  • MENTEE GROUP: English-speaker
  • MENTEE GROUP: Access to electronic device that can be used for communication
  • MENTEE GROUP: Eastern Cooperative Oncology Group (ECOG) score less than or equal to 2
  • CAREGIVER GROUP: Ability to understand and the willingness to sign a written informed consent document
  • CAREGIVER GROUP: Age 18 or older at the time of consent (upper age limit 89)
  • CAREGIVER GROUP: Caregiver of patient diagnosed with head and neck cancer who is also enrolled in the study
  • CAREGIVER GROUP: English-speaker
  • CAREGIVER GROUP: Access to electronic device that can be used for communication

Exclusion Criteria:

  • MENTEE GROUP: Mentee must not be regularly engaging in other support programs at the start of the study intervention
  • MENTEE GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol
  • MENTEE GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator
  • CAREGIVER GROUP: Caregivers must not be regularly engaging in other support programs at the start of the study intervention
  • CAREGIVER GROUP: Undergoing active professional treatment for cognitive or emotional difficulties or neurological deficits that preclude adherence to the study protocol
  • CAREGIVER GROUP: Any other social, emotional, or personal situation that will preclude adherence to the study protocol, at the discretion of the investigator

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Supportive Care (peer support program)

Patients ("mentees") participate in the peer support program by being matched with and meeting with a peer mentor, either virtually or in-person, during the study.

Caregivers of enrolled mentees may also participate on an optional basis by completing study surveys; however, caregivers will not directly participate in the peer mentorship intervention.
Andet: Undersøgelsesadministration
Hjælpestudier
Andet: Interview
Hjælpestudier
Andet: Supportive Care
Participate in peer support program
Andre navne:
  • Understøttende terapi
  • Symptomhåndtering
  • Terapi, støttende

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Proportion of mentees meeting with their mentor match at least once
Tidsramme: Up to 6 months
Will be reported with 95% asymptotic confidence interval.
Up to 6 months

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Utilization of the mentorship program
Tidsramme: Up to 6 months
Mean and standard deviation will be reported for number of times the mentor and mentee have made contact.
Up to 6 months
Mentorship conversation topics
Tidsramme: Up to 6 months
Proportions of categories will be reported for topics discussed between mentor and mentee.
Up to 6 months
Rating scale for match
Tidsramme: Up to 6 months
Mean and standard deviation will be reported for rating scale for match (in terms of similar demographics and cancer experience). This will be on a 1-10 scale, with 10 being the most similar match.
Up to 6 months
Qualitative data on the benefits and challenges of the mentorship program
Tidsramme: Up to 6 months
A subset of mentees (estimated n=10-15) will complete structured exit interviews at 6 months. Interviews will explore perceived benefits, challenges, barriers to engagement, impact on decision-making, and recommendations for program improvement.
Up to 6 months
Satisfaction with peer mentor contacts
Tidsramme: Up to 6 months
Satisfaction will be measured using a survey that was used in a prior pilot study on a one-on-one cancer peer support program by Valanjow and Weis (2024). The survey contains 14 statements and mentees will be asked to rate how much they feel the statement applies. The scale ranges from 1-5 (1= not applicable and 5=fully applies). Mean and standard deviation of the Likert score will be reported for each item at each time point.
Up to 6 months
Demographic differences between matched mentees who meet with their mentor and those who do not
Tidsramme: Up to 6 months
Descriptive univariate analysis to evaluate demographic differences between matched mentees who meet with their mentor and those who do not.
Up to 6 months

Andre resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Mentee psychosocial well-being over time
Tidsramme: Up to 6 months
Mentees will complete short surveys analyzing coping, anxiety and depression at three different time points to track changes over time.
Up to 6 months
Caregiver burden over time (optional)
Tidsramme: Up to 6 months
Caregivers will complete surveys on caregiver burden at three different time points to track changes over time.
Up to 6 months

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Sponsor

OHSU Knight Cancer Institute

Samarbejdspartnere

Oregon Health and Science University

Efterforskere

  • Ledende efterforsker: Ryan J Li, MD, OHSU Knight Cancer Institute

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

16. juli 2026

Primær færdiggørelse (Anslået)

31. december 2027

Studieafslutning (Anslået)

31. december 2027

Datoer for studieregistrering

Først indsendt

15. juni 2026

Først indsendt, der opfyldte QC-kriterier

18. juni 2026

Først opslået (Faktiske)

24. juni 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

15. juli 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

13. juli 2026

Sidst verificeret

1. juli 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • STUDY00029208 (Anden identifikator: OHSU Knight Cancer Institute)
  • NCI-2026-00407 (Registry Identifier: CTRP (Clinical Trial Reporting Program))

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Kliniske forsøg med Undersøgelsesadministration

Søg i lignende forsøg

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

CROs by country

CROs in Congo, DR of

Betingelser

Sjældne sygdomme

Narkotikainterventioner

Kosttilskud

Sponsor / samarbejdspartnere

Placeringer

Abonner